Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder

Name: Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder
SKU: 2783
Availability: InStock

$30.00

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 40 No. 1 Articles Tags: amygdala, brain-imaging-techniques, christian-schmahl, eric-vermetten, j-douglas-bremner, md, memory, olfaction, phd, ptsd, steven-m-southwick

Description

Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder

Description

Eric Vermetten, MD, PhD

ORIGINAL RESEARCH

Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Post Traumatic Stress Disorder

Eric Vermetten, MD, PhD, Christian Schmahl, MD, Steven M. Southwick, MD, and
J. Douglas Bremner, MD

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?

Eric Vermetten, MD, PhD: Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Posttraumatic Stress Disorder

Description

Eric Vermetten, MD, PhD

ORIGINAL RESEARCH

Positron Tomographic Emission Study of Olfactory Induced Emotional Recall in Veterans with and without Combat-Related Post Traumatic Stress Disorder

Eric Vermetten, MD, PhD, Christian Schmahl, MD, Steven M. Southwick, MD, and J. Douglas Bremner, MD

Related products

New Goals in the Treatment of Depression: Moving Toward Recovery By Michael E. Thase, MD, and Philip T. Ninan, MD

Eduard Parellada, MD, MSc, PhD: Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations

David V. Sheehan: An Open-Label Study of Tiagabine in Panic Disorder

Eduardo J. Aguilar, MD, PhD: Do Antipsychotic Drugs Influence Suicidal Behavior in Schizophrenia?

Eric Vermetten, MD, PhD, Christian Schmahl, MD, Steven M. Southwick, MD, and
J. Douglas Bremner, MD